A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
Clinical trial NCT04629248 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04629248
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-25
- Primary completion
- 2025-12-22
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.